Study: Drug interactions may be imminent among antidepressant users

ANN ARBOR, Mich. — Many older Americans prescribed antidepressants may be taking medication that could adversely interact with the antidepressant, a new study found.

The Thomson Reuters study — sponsored by Sanofi-Aventis and published in the American Journal for Geriatric Psychiatry — found that there are more challenges in prescribing antidepressants to older Americans. Among 39,512 new antidepressant users ages 65 years and older, 25.4% were prescribed antidepressants and another medication that could cause a major interaction, while an additional 36.1% had potential moderate interactions. The remaining 38.5% of respondents had minor or no interactions.

What's more, the study found, the likelihood that users would have to switch antidepressants because of adverse interactions between medications was 19.5%. Many side effects reported by patients included insomnia, somnolence and drowsiness.

"We found a concerning degree of potentially harmful drug combinations being prescribed to seniors. These findings reinforce the need for clinicians to be aware of potential drug-drug interactions and the importance of close patients monitoring," said Tami Mark, the paper's lead author and director of analytic strategies at Thomson Reuters.

Recommended stories

Login or Register to post a comment.